Black Diamond Therapeutics

About:

Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.

Website: https://www.blackdiamondtherapeutics.com/

Top Investors: Deerfield, New Enterprise Associates, Perceptive Advisors, RA Capital Management, Invus

Description:

Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery and development of small-molecule. It is engaged in discovering and developing small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, Mutation-Allostery-Pharmacology, which targets cancer mutations. Black Diamond focuses on the discovery and development of precision medicines for cancer that are directed against a novel class of allosteric mutant oncogenes. It also targets undrugged mutations in patients with genetically defined cancers for whom limited treatment options currently exist. It is built upon a deep understanding of cancer genetics, protein structure and function, and medicinal chemistry.